Linda Conrad, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 5th St., Hayti, SD 57241 Phone: 605-783-3607 Fax: 605-783-3259 |
Heather Lynne Hansen, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 5th Street, Hayti, SD 57241 Phone: 605-783-3607 |
Marci Saathoff, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 5th Street, Hayti, SD 57241 Phone: 605-783-3607 Fax: 605-783-3259 |
Alysha Johnson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 5 Street, Hayti, SD 57241 Phone: 605-783-3607 Fax: 605-783-3259 |
Rita Wiese Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 5th St, Hayti, SD 57241 Phone: 605-783-3671 |
Carrie Niles, MA-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 5th St, Hayti, SD 57241 Phone: 605-783-3607 Fax: 605-783-3259 |
Lois Marie Lux, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 5th St., Nesc, Hayti, SD 57241 Phone: 605-783-3607 Fax: 605-783-3259 |
Mrs. Deb Jean Lauseng, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 5th St., Hayti, SD 57241 Phone: 605-783-3607 |
Deb Tiefenthaler Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 5th St, Hayti, SD 57241 Phone: 605-783-3607 |
Rochelle Schmidt Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 5th St, Hayti, SD 57241 Phone: 605-783-3607 |
Christy Kay Busskohl, M.S, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 5th St., Hayti, SD 57241 Phone: 605-783-3607 Fax: 605-783-3259 |
Cheryl Keller-knudson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 310 5th St., Hayti, SD 57241 Phone: 605-783-3607 Fax: 605-783-3259 |
News Archive
TrialScope, the global leader in clinical trial transparency and compliance solutions, today announced general availability of the latest release of the PharmaCM platform (v.2.2) that automates and manages clinical trial results reporting via the European Medicines Agency's European Clinical Trials Database (EudraCT).
Sebia, the world leader in capillary electrophoresis, today announces that Capillarys 3 Tera now has the CE mark for HbA1c and serum protein testing, and immunotyping. The CE mark for these tests is the first step in bringing the Capillarys 3 suite to market.
Results of a new study demonstrated that initial combination therapy with Welchol® (colesevelam HCl) 3.75 g/d and metformin (initiated at 850 mg/d; uptitrated to 1700 mg/d thereafter) significantly improved glycemic and lipid control in drug-naive adult type 2 diabetes patients with high LDL cholesterol (LDL-C).
One American dies from suicide every 12.8 minutes, making suicide the tenth leading cause of death in the United States according to the American Foundation for Suicide Prevention.
The UK has joined the US, Europe and the World Health Organisation by including loss of smell or taste as an officially recognized symptom of Covid-19 – thanks in part to an international research project involving Professor Carl Philpott at the University of East Anglia.
› Verified 9 days ago